Navigation Links
DIA Conference to Focus on Drug-Induced Injury of Liver, Heart, Kidney, and Skin
Date:9/24/2013

HORSHAM, Pa. (PRWEB) September 24, 2013

The DIA conference Drug-Induced Injury of Liver, Heart, Kidney, and Skin: Employing Recent Advances to Improve Patient Safety and Speed Up the Pipeline will be held Oct. 15 to 17, at the Bethesda North Marriott Hotel & Conference Center in North Bethesda, Md., at 5701 Marinelli Road. The conference will focus on risk assessment of drug toxicity and address the obstacles faced by those working in pharmaceutical safety across the drug life cycle.

“Establishing the safety of new drug candidates remains a challenge in the development process. This conference will explore new strategies for risk assessment and mitigation and provide the latest updates on drug-induced organ injury from the United States, Europe and Japan,” said Susan Cantrell, director of DIA North America.

The two-and-a-half-day conference aimed at drug safety professionals will kick off with a welcome address by William W. Gregory, Ph.D., senior director of safety and risk management at Pfizer. The first session, “Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury,” will be chaired by Aliza M. Thompson, M.D., a clinical team leader with the Center for Drug Evaluation and Research, Food and Drug Administration, U.S.

Workshop sessions will include:

  •     Prediction and Prevention of Serious Drug-Induced Skin Injury, Oct. 15, 1:30 p.m.: Serious skin reactions are rare but can be life-threatening and leave people with lasting disabilities. Experts will discuss what is known about biomarkers for risk of serious skin reactions and the identification of patients at—and drugs with—the greatest risk. Edward Stewart Geary, M.D., senior vice president of corporate medical affairs at Eisai Co., Ltd., Japan, will chair this session.
  •     Drug-Induced Liver Injury: Models and Biomarkers, Oct. 16, 8:30 a.m.: One of the key challenges for the prediction and assessment of idiosyncratic drug-induced liver injury in drug development is the lack of suitable models and safety biomarkers. This session will present examples of recent advances in both areas based on collaborative research. Michael Merz, M.D., director of discovery and investigative safety at Novartis Institutes for BioMedical Research, Switzerland, will chair this session.
  •     Risk Factors for Idiosyncratic Drug-Induced Liver Injury, Oct. 16, 3 p.m.: Master clinicians will discuss whether underlying liver diseases of various types can be distinguished from drug-induced injury and if the diseases may either enhance or diminish drug effects. This session will be chaired by John R. Senior, M.D., associate director for science, Office of Surveillance and Epidemiology, Food and Drug Administration, U.S.
  •     Models and Biomarkers of Drug-Induced Cardiac Injury, Oct. 17, 10:30 a.m.: This session will explore bench-to-bedside approaches to identifying and monitoring drug-induced cardiac injury as well as innovative approaches to in vitro modeling. Brian R. Berridge, DVM, Ph.D., director of worldwide animal research strategy at GlaxoSmithKline Research and Development, U.S., will chair this session.

ABOUT DIA: DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C.; and Latin America. Visit our website at http://www.diahome.org and follow DIA at: LinkedIn, Twitter, YouTube, Facebook, Flickr and Pinterest.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11156907.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Elsevier organizes label-free technologies conference
2. NJ stroke researchers report advances in spatial neglect research at AAN Conference
3. Blending conference translates substance abuse research into practice
4. International conference to explore health of descendants of transatlantic slave trade
5. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
6. Nobel laureate to keynote international pharmaceutical conference at URI
7. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
8. Snoring Isn't Sexy Member Dr. Mark Levy attends Academy of Clinical Sleep Disorders Disciplines Conference in Phoenix, Arizona
9. AuntMinnie Begins Live Video Stream of ISCT Conference Proceedings
10. NOVAtime Solutions to be showcased at Booth #1821 in the upcoming Society for Human Resource Management (SHRM) Annual Conference and Exposition
11. International Nanomedicine Conference bound for Sydney: July 2-4, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
Breaking Medicine Technology: